Crossmark

Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1

Crossref DOI link: https://doi.org/10.1186/s12974-018-1221-6

Published Online: 2018-06-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Luo, Wen-di

Min, Jia-wei

Huang, Wen-Xian

Wang, Xin

Peng, Yuan-yuan

Han, Song

Yin, Jun

Liu, Wan-Hong

He, Xiao-Hua

Peng, Bi-Wen https://orcid.org/0000-0002-5599-6779
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81370737, 81571481, 81601325)

Independent Scientific Research Project Fund of Wuhan University (2042017kt0066)
License Information

Text and Data Mining valid from 2018-06-20
More Information

Article History

Received: 30 March 2018

Accepted: 14 June 2018

First Online: 20 June 2018

Ethics approval

: All experimental procedures and animal care were approved by the Wuhan Medical University Ethics Committee and were conducted in accordance with the guidelines of the National Institutes of Health on the care and use of animals.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.